Pathologic left ventricular remodeling and valvular heart disease may contribute to the clinical presentation and outcomes of patients presenting with heart failure, and limit the effectiveness of guideline-directed medical therapy. Although surgical interventions including surgical ventricular restoration techniques and valve repair or replacement are effective therapies, there is growing evidence that transcatheter interventions may be options for patients with persistent symptoms of heart failure despite optimal medical therapy, where surgical options may be limited. This scientific statement will review the current available and investigational percutaneous strategies for the management of structural contributors to heart failure: dilated left ventricular cardiomyopathies and valvular heart disease.
Keyphrases
- left ventricular
- heart failure
- cardiac resynchronization therapy
- atrial fibrillation
- aortic stenosis
- mitral valve
- hypertrophic cardiomyopathy
- aortic valve
- left atrial
- physical activity
- acute myocardial infarction
- healthcare
- acute heart failure
- pulmonary hypertension
- stem cells
- systematic review
- clinical trial
- radiation therapy
- minimally invasive
- oral anticoagulants
- adipose tissue
- neoadjuvant chemotherapy
- smoking cessation
- coronary artery disease
- skeletal muscle
- metabolic syndrome
- squamous cell carcinoma
- lymph node
- mesenchymal stem cells
- transcatheter aortic valve replacement
- open label
- radiofrequency ablation
- sleep quality